These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21689377)

  • 21. Pharmacophore modeling of pretomanid (PA-824) derivatives for antitubercular potency against replicating and non-replicating
    Aher RB; Sarkar D
    J Biomol Struct Dyn; 2021 Feb; 39(3):889-900. PubMed ID: 31983295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular Quantum Similarity, Chemical Reactivity and Database Screening of 3D Pharmacophores of the Protein Kinases A, B and G from Mycobacterium tuberculosis.
    Morales-Bayuelo A
    Molecules; 2017 Jun; 22(6):. PubMed ID: 28635627
    [No Abstract]   [Full Text] [Related]  

  • 23. Development of selective DprE1 inhibitors: Design, synthesis, crystal structure and antitubercular activity of benzothiazolylpyrimidine-5-carboxamides.
    Chikhale R; Menghani S; Babu R; Bansode R; Bhargavi G; Karodia N; Rajasekharan MV; Paradkar A; Khedekar P
    Eur J Med Chem; 2015; 96():30-46. PubMed ID: 25874329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-activity relationships of antitubercular nitroimidazoles. 3. Exploration of the linker and lipophilic tail of ((s)-2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazin-6-yl)-(4-trifluoromethoxybenzyl)amine (6-amino PA-824).
    Cherian J; Choi I; Nayyar A; Manjunatha UH; Mukherjee T; Lee YS; Boshoff HI; Singh R; Ha YH; Goodwin M; Lakshminarayana SB; Niyomrattanakit P; Jiricek J; Ravindran S; Dick T; Keller TH; Dartois V; Barry CE
    J Med Chem; 2011 Aug; 54(16):5639-59. PubMed ID: 21755942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-activity relationships of pyrrole hydrazones as new anti-tuberculosis agents.
    Lessigiarska I; Pajeva I; Prodanova P; Georgieva M; Bijev A
    Med Chem; 2012 May; 8(3):462-73. PubMed ID: 22530903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and evaluation of pretomanid (PA-824) oxazolidinone hybrids.
    Rakesh ; Bruhn DF; Scherman MS; Singh AP; Yang L; Liu J; Lenaerts AJ; Lee RE
    Bioorg Med Chem Lett; 2016 Jan; 26(2):388-391. PubMed ID: 26711150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and anti-tubercular activity of 2-nitroimidazooxazines with modification at the C-7 position as PA-824 analogs.
    Kang YG; Park CY; Shin H; Singh R; Arora G; Yu CM; Lee IY
    Bioorg Med Chem Lett; 2015 Sep; 25(17):3650-3. PubMed ID: 26199118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 6-Nitro-2,3-dihydroimidazo[2,1-b][1,3]thiazoles: Facile synthesis and comparative appraisal against tuberculosis and neglected tropical diseases.
    Thompson AM; Blaser A; Palmer BD; Anderson RF; Shinde SS; Launay D; Chatelain E; Maes L; Franzblau SG; Wan B; Wang Y; Ma Z; Denny WA
    Bioorg Med Chem Lett; 2017 Jun; 27(11):2583-2589. PubMed ID: 28462832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biarylmethoxy 2-nitroimidazooxazine antituberculosis agents: Effects of proximal ring substitution and linker reversal on metabolism and efficacy.
    Thompson AM; Blaser A; Palmer BD; Franzblau SG; Wan B; Wang Y; Ma Z; Denny WA
    Bioorg Med Chem Lett; 2015 Sep; 25(18):3804-9. PubMed ID: 26253632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The antitubercular activity of various nitro(triazole/imidazole)-based compounds.
    Papadopoulou MV; Bloomer WD; Rosenzweig HS
    Bioorg Med Chem; 2017 Nov; 25(21):6039-6048. PubMed ID: 28993106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimycobacterial activity evaluation, time-kill kinetic and 3D-QSAR study of C-(3-aminomethyl-cyclohexyl)-methylamine derivatives.
    Kumar D; Raj KK; Bailey M; Alling T; Parish T; Rawat DS
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1365-9. PubMed ID: 23357633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and biological evaluation of sugar-derived chiral nitroimidazoles as potential antimycobacterial agents.
    Mugunthan G; Sriram D; Yogeeswari P; Ravindranathan Kartha KP
    Carbohydr Res; 2011 Sep; 346(13):1760-6. PubMed ID: 21714959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3D-QSAR and molecular modeling studies on 2,3-dideoxy hexenopyranosid-4-uloses as anti-tubercular agents targeting alpha-mannosidase.
    Shah P; Saquib M; Sharma S; Husain I; Sharma SK; Singh V; Srivastava R; Shaw AK; Siddiqi MI
    Bioorg Chem; 2015 Apr; 59():91-6. PubMed ID: 25727263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and structure-activity relationships of aza- and diazabiphenyl analogues of the antitubercular drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824).
    Kmentova I; Sutherland HS; Palmer BD; Blaser A; Franzblau SG; Wan B; Wang Y; Ma Z; Denny WA; Thompson AM
    J Med Chem; 2010 Dec; 53(23):8421-39. PubMed ID: 21069962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-activity relationships on purine and 2,3-dihydropurine derivatives as antitubercular agents: a data mining approach.
    Pietra D; Imbriani M; Borghini A; Giorgi I; Settimo FD; Breschi MC; Campa M; Batoni G; Brancatisano FL; Bianucci AM
    Chem Biol Drug Des; 2011 Oct; 78(4):718-24. PubMed ID: 21756283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and structure-activity relationships for extended side chain analogues of the antitubercular drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824).
    Palmer BD; Sutherland HS; Blaser A; Kmentova I; Franzblau SG; Wan B; Wang Y; Ma Z; Denny WA; Thompson AM
    J Med Chem; 2015 Apr; 58(7):3036-59. PubMed ID: 25781074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Schiff bases of indoline-2,3-dione (isatin) derivatives and nalidixic acid carbohydrazide, synthesis, antitubercular activity and pharmacophoric model building.
    Aboul-Fadl T; Bin-Jubair FA; Aboul-Wafa O
    Eur J Med Chem; 2010 Oct; 45(10):4578-86. PubMed ID: 20696500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, Synthesis, and Characterization of Some Hybridized Pyrazolone Pharmacophore Analogs against Mycobacterium tuberculosis.
    Krishnasamy SK; Namasivayam V; Mathew S; Eakambaram RS; Ibrahim IA; Natarajan A; Palaniappan S
    Arch Pharm (Weinheim); 2016 May; 349(5):383-97. PubMed ID: 27135906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PA-824 kills nonreplicating Mycobacterium tuberculosis by intracellular NO release.
    Singh R; Manjunatha U; Boshoff HI; Ha YH; Niyomrattanakit P; Ledwidge R; Dowd CS; Lee IY; Kim P; Zhang L; Kang S; Keller TH; Jiricek J; Barry CE
    Science; 2008 Nov; 322(5906):1392-5. PubMed ID: 19039139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.